Joseph J. Kaberlein

540 total citations
6 papers, 344 citations indexed

About

Joseph J. Kaberlein is a scholar working on Molecular Biology, Hematology and Infectious Diseases. According to data from OpenAlex, Joseph J. Kaberlein has authored 6 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Hematology and 0 papers in Infectious Diseases. Recurrent topics in Joseph J. Kaberlein's work include Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (4 papers) and RNA Interference and Gene Delivery (3 papers). Joseph J. Kaberlein is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (4 papers) and RNA Interference and Gene Delivery (3 papers). Joseph J. Kaberlein collaborates with scholars based in United States, Singapore and China. Joseph J. Kaberlein's co-authors include Michael J. Thirman, Roger Luo, Paul Polak, Federico Simone, Denise Levitan, Fuhong He, Jun Wu, Ryan J. Mattison, Shyam Prabhakar and Jingfang Dong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Molecular Biology of the Cell.

In The Last Decade

Joseph J. Kaberlein

6 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph J. Kaberlein United States	6	307	98	36	28	28	6	344
Xinghui Zhao China	8	194 0.6×	81 0.8×	33 0.9×	35 1.3×	21 0.8×	16	245
Lisa von Paleske Germany	4	245 0.8×	86 0.9×	51 1.4×	35 1.3×	49 1.8×	6	316
Tanya A. Kranenburg United States	5	155 0.5×	88 0.9×	26 0.7×	27 1.0×	20 0.7×	5	225
Dimitris Karamitros Greece	9	201 0.7×	100 1.0×	37 1.0×	34 1.2×	84 3.0×	14	306
Anne-Katrine Frank Denmark	7	172 0.6×	100 1.0×	21 0.6×	27 1.0×	55 2.0×	9	235
Petra Zeisberger Germany	5	268 0.9×	99 1.0×	58 1.6×	36 1.3×	63 2.3×	11	349
Roberto Avellino Netherlands	5	174 0.6×	112 1.1×	31 0.9×	21 0.8×	65 2.3×	10	246
Roman Galeev Sweden	8	228 0.7×	123 1.3×	38 1.1×	44 1.6×	65 2.3×	14	358
Alix Rousseau France	5	199 0.6×	75 0.8×	30 0.8×	54 1.9×	40 1.4×	6	281

Countries citing papers authored by Joseph J. Kaberlein

Since Specialization

Citations

This map shows the geographic impact of Joseph J. Kaberlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Kaberlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Kaberlein more than expected).

Fields of papers citing papers by Joseph J. Kaberlein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph J. Kaberlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Kaberlein. The network helps show where Joseph J. Kaberlein may publish in the future.

Co-authorship network of co-authors of Joseph J. Kaberlein

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph J. Kaberlein. A scholar is included among the top collaborators of Joseph J. Kaberlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph J. Kaberlein. Joseph J. Kaberlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Li, Bingjie, Joseph J. Kaberlein, Roger Luo, et al.. (2013). Regulation of MEIS1 by distal enhancer elements in acute leukemia. Leukemia. 28(1). 138–146. 15 indexed citations

2.

Wang, Qian-Fei, George Y. Wu, Shuangli Mi, et al.. (2011). MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood. 117(25). 6895–6905. 98 indexed citations

3.

Byun, Jung S., Madeline Wong, Wenwu Cui, et al.. (2009). Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes. Proceedings of the National Academy of Sciences. 106(46). 19286–19291. 52 indexed citations

4.

Polak, Paul, Federico Simone, Joseph J. Kaberlein, Roger Luo, & Michael J. Thirman. (2003). ELL and EAF1 are Cajal Body Components That Are Disrupted in MLL-ELL Leukemia. Molecular Biology of the Cell. 14(4). 1517–1528. 37 indexed citations

5.

Simone, Federico, Roger Luo, Paul Polak, Joseph J. Kaberlein, & Michael J. Thirman. (2003). ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood. 101(6). 2355–2362. 68 indexed citations

6.

Simone, Federico, Paul Polak, Joseph J. Kaberlein, et al.. (2001). EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein. Blood. 98(1). 201–209. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact